Variants of the Adiponectin (ADIPOQ) and Adiponectin Receptor 1 (ADIPOR1) Genes and Colorectal Cancer Risk

Virginia G. Kaklamani, MD, DSc; Kari B. Wisinski, MD; Maureen Sadim, BS; Cassandra Gulden, MS; Albert Do, BS; Kenneth Offit, MD, MPH; John A. Baron, MD; Habibul Ahsan, MD, MPH; Christos Mantzoros, MD, MPH; Boris Pasche, MD, PhD

JAMA. 2008;300(13):1523-1531.

Rapid Testing for Malaria in Settings Where Microscopy is Available and Peripheral Clinics Where Only Presumptive Treatment is Available: A Randomised Controlled Trial in Ghana

Evelyn K Ansah, district director of health services1, Solomon Narh-Bana, research officer1, Michael Epokor, research officer2, Samson Akanpigbiam, research officer2, Alberta Amu Quartey, medical superintendent1, John Gyapong, director3, Christopher J M Whitty, professor4

1 Dangme West District Health Directorate, Dodowa, Ghana, 2 Dodowa Health Research Centre, Dodowa, Ghana, 3 Research and Development Division, Ghana Health Service, Accra, Ghana, 4 London School of Hygiene & Tropical Medicine, London

Correspondence to: E K Ansah This e-mail address is being protected from spambots. You need JavaScript enabled to view it

 

Glycosylated Hemoglobin and Cardiovascular Risk in Nondiabetic Adults

Even within the normal range, HbA1c level correlated with diabetes risk.

Glycosylated hemoglobin (HbA1c) is used most commonly as an indicator of glycemic control in patients with known diabetes. But do variations of HbA1c level within the "normal" range predict diabetes and other clinical outcomes? To answer this question, researchers measured HbA1c in 11,000 adults (mean age, 57) who had no histories of diabetes or cardiovascular disease and correlated HbA1c levels with long-term outcomes.